➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Colorcon
Johnson and Johnson
Medtronic
Dow

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Patent: 8,758,816

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,758,816
Title:Compositions comprising azelastine and methods of use thereof
Abstract: The present invention provides pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt or ester thereof including azelastine hydrochloride, and optionally one or more additional active agents. Preferred such compositions further comprise one or more pharmaceutically acceptable carriers or excipients that reduce the amount of post-nasal drip, and/or that minimize or mask the unpleasant bitter taste associated with post-nasal drip, of the compositions into the oral cavity, upon intranasal or ocular administration of the compositions. Especially effective excipients used in the compositions of the present invention are hypromellose as a viscosity modifier and sucralose as a taste-masking agent. The invention also generally relates to pharmaceutical compositions comprising one or more active pharmaceutical ingredients, such as azelastine or pharmaceutically acceptable salts or esters thereof including azelastine hydrochloride, particularly wherein the compositions are provided in unit dosage form. In certain embodiments, the invention provides such unit dosage pharmaceutical compositions comprising azelastine hydrochloride formulated for use as nasal sprays and/or ocular solutions or drops. The invention also provides methods of treating or preventing certain disorders, or symptomatic relief therefrom, by administering the compositions of the invention to a patient, e.g., for the symptomatic relief of a variety of allergic and non-allergic conditions, particularly conjunctivitis, sinusitis, rhinitis and rhinosinusitis. The compositions and methods of the present invention provide significant value in terms of patient acceptability, convenience, and compliance.
Inventor(s): Fuge; Dennis (Somerset, NJ), Higson; John (Plymouth Meeting, PA), Roecklein; Bryan A. (Somerset, NJ), Balwani; Gul (West Windsor, NJ), D\'Addio; Alexander D. (Piscataway, NJ)
Assignee: Meda Pharmaceuticals Inc. (Somerset, NJ)
Application Number:12/569,548
Patent Claims:see list of patent claims

Details for Patent 8,758,816

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Seqirus Vaccines Limited FLUVIRIN influenza virus vaccine Injection 103837 1998-11-03 ⤷  Try it Free 2024-11-24
Hoffmann-la Roche Inc. PEGASYS peginterferon alfa-2a Injection 103964 2002-10-16 ⤷  Try it Free 2024-11-24
Hoffmann-la Roche Inc. PEGASYS peginterferon alfa-2a Injection 103964 2004-01-07 ⤷  Try it Free 2024-11-24
Hoffmann-la Roche Inc. PEGASYS peginterferon alfa-2a Injection 103964 2011-09-29 ⤷  Try it Free 2024-11-24
Hoffmann-la Roche Inc. PEGASYS COPEGUS COMBINATION PACK peginterferon alfa-2a and ribavirin 125083 2004-06-04 ⤷  Try it Free 2024-11-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Merck
Baxter
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.